Haemonetics Corporation
A maker of medical devices and software for collecting, processing, and managing blood and plasma, Haemonetics builds the machines and disposable kits used by blood banks, hospitals, and plasma centers — including its NexSys plasma collection systems and apheresis devices that pull out specific components like platelets. The company was founded in 1971 by Dr. Allen "Jack" Latham, Jr., who invented the "Latham Bowl," a transparent disposable centrifuge bowl that automated blood separation. Its name blends "haemo," the Greek word for blood, with "-netics," a nod to genetics and cybernetics.
Granted 632.6K · Sold 4.5K
Granted 127.2K · Sold 65.9K
Granted 68.0K
Granted 40.2K · Sold 604
Granted 35.1K · Sold 11.6K
Granted 9.9K · Sold 10.2K
Granted 9.9K
Granted 9.9K · Bought 1.4K · Sold 8.0K
Granted 25.2K · Sold 10.7K
Granted 2.7K
Granted 9.9K
Granted 41.7K · Sold 18.6K
Granted 9.9K
Granted 9.9K
Granted 9.9K
Granted 40.7K
Granted 7.1K
Granted 6.9K
Granted 33.2K
Granted 868 · Sold 475
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Simon, ChristopherPresident & CEO, Director · 28 transactions | +131.9% | 444.7K | 632.6K | — | 4.5K |
| Basil Michelle LEVP and General Counsel · 38 transactions | +79.2% | 68.8K | 127.2K | — | 65.9K |
| DArecca JamesEVP, Chief Financial Officer · 18 transactions | — | 54.4K | 68.0K | — | — |
| Miller Laurie A.SVP, Human Resources · 31 transactions | — | 41.0K | 40.2K | — | 604 |
| Llorens JosepEVP, Global Manufacturing · 23 transactions | +111.6% | 30.9Kas of May 2024 | 35.1K | — | 11.6K |
| Dockendorff Charles JDirector · 5 transactions | — | 25.0Kas of Jul 2025 | 9.9K | — | 10.2K |
| Abernathy Robert EDirector · 4 transactions | +65.2% | 25.0Kas of Jul 2025 | 9.9K | — | — |
| Kroll Mark WDirector · 6 transactions | +15.1% | 24.8K | 9.9K | 1.4K | 8.0K |
| Lingamneni AnilaEVP, Chief Technology Officer · 19 transactions | +50.2% | 21.3Kas of Jul 2024 | 25.2K | — | 10.7K |
| Burzik Catherine MDirector · 1 transaction | +16.2% | 19.5Kas of Aug 2022 | 2.7K | — | — |
| Zane Ellen MDirector · 4 transactions | +103.6% | 19.4Kas of Jul 2025 | 9.9K | — | — |
| Strong Stewart WPresident, Global Hospital · 29 transactions | +42.2% | 18.2Kas of Jul 2024 | 41.7K | — | 18.6K |
| Pomeroy ClaireDirector · 4 transactions | +140.5% | 16.9Kas of Jul 2025 | 9.9K | — | — |
| Coyle Michael JDirector · 4 transactions | +178% | 15.4Kas of Jul 2025 | 9.9K | — | — |
| Johnson Lloyd EmersonDirector · 4 transactions | +320.3% | 12.9Kas of Jul 2025 | 9.9K | — | — |
| Galvin RoyEVP, Chief Commercial Officer · 12 transactions | — | 12.3K | 40.7K | — | — |
| Bryant Diane MDirector · 3 transactions | — | 7.1Kas of Jul 2025 | 7.1K | — | — |
| Maunsell Farris MaryanneVP, Chief Accounting Officer · 10 transactions | — | 6.2K | 6.9K | — | — |
| Chan FrankEVP, Chief Operating Officer · 3 transactions | — | 5.4K | 33.2K | — | — |
| Goldstein DanVP, Corporate Controller · 5 transactions | +9.7% | 4.4Kas of Jun 2022 | 868 | — | 475 |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -129.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.